Drug interactions for the following drug(s)

Interactions between your selected drugs

The metabolism of Irbesartan can be decreased when combined with Zolpidem.

The metabolism of Carvedilol can be decreased when combined with Zolpidem.

cephalexin<>gabapentin enacarbil

Applies to: Cephalexin 500 MG Oral Capsule <> gabapentin 300 MG Oral Capsule

Cephalexin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.

The metabolism of Cephalexin can be decreased when combined with Irbesartan.

The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Hydrochlorothiazide.

Gabapentin may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.

The risk or severity of hyperkalemia can be increased when Irbesartan is combined with Carvedilol.

zolpidem<>gabapentin enacarbil

Applies to: AMBIEN 5 MG Oral Tablet <> gabapentin 300 MG Oral Capsule

Gabapentin enacarbil may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.

Hydrochlorothiazide may increase the hypokalemic activities of Digoxin.

digoxin<>gabapentin enacarbil

Applies to: Digoxin 0.125 MG Oral Tablet <> gabapentin 300 MG Oral Capsule

Gabapentin enacarbil may decrease the excretion rate of Digoxin which could result in a higher serum level.

gabapentin<>gabapentin enacarbil

Applies to: gabapentin 300 MG Oral Capsule <> gabapentin 300 MG Oral Capsule

The risk or severity of adverse effects can be increased when Gabapentin is combined with Gabapentin enacarbil.

gabapentin enacarbil<>cephalexin anhydrous

Applies to: gabapentin 300 MG Oral Capsule <> Cephalexin 500 MG Oral Capsule

Cephalexin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.

The therapeutic efficacy of Carvedilol can be increased when used in combination with Hydrochlorothiazide.

Hydrochlorothiazide may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.

The serum concentration of Digoxin can be increased when it is combined with Carvedilol.

digoxin<>cephalexin anhydrous

Applies to: Digoxin 0.125 MG Oral Tablet <> Cephalexin 500 MG Oral Capsule

Cephalexin may decrease the excretion rate of Digoxin which could result in a higher serum level.

Cephalexin may decrease the excretion rate of Digoxin which could result in a higher serum level.

No other interactions were found between your selected drugs.

Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.

Interactions between your selected drugs

Drug1 (rxcui = 854878, name = zolpidem tartrate 5 MG Oral Tablet [Ambien], tty = SBD). Drug2 (rxcui = 310792, name = hydrochlorothiazide 12.5 MG / irbesartan 150 MG Oral Tablet, tty = SCD). Drug1 is resolved to zolpidem, Drug2 is resolved to irbesartan and interaction asserted in DrugBank between Zolpidem and Irbesartan.

Drug1 (rxcui = 860512, name = 24 HR carvedilol phosphate 10 MG Extended Release Oral Capsule [Coreg], tty = SBD). Drug2 (rxcui = 854878, name = zolpidem tartrate 5 MG Oral Tablet [Ambien], tty = SBD). Drug1 is resolved to carvedilol, Drug2 is resolved to zolpidem and interaction asserted in DrugBank between Carvedilol and Zolpidem.

cephalexin<>gabapentin enacarbil

Applies to: Cephalexin 500 MG Oral Capsule <> gabapentin 300 MG Oral Capsule

Drug1 (rxcui = 309114, name = cephalexin 500 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 310431, name = gabapentin 300 MG Oral Capsule, tty = SCD). Drug1 is resolved to cephalexin, Drug2 is resolved to gabapentin enacarbil and interaction asserted in DrugBank between Cephalexin and Gabapentin enacarbil.

Drug1 (rxcui = 309114, name = cephalexin 500 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 310792, name = hydrochlorothiazide 12.5 MG / irbesartan 150 MG Oral Tablet, tty = SCD). Drug1 is resolved to cephalexin, Drug2 is resolved to irbesartan and interaction asserted in DrugBank between Cephalexin and Irbesartan. Drug1 is resolved to cephalexin, Drug2 is resolved to hydrochlorothiazide and interaction asserted in DrugBank between Cephalexin and Hydrochlorothiazide.

Drug1 (rxcui = 310792, name = hydrochlorothiazide 12.5 MG / irbesartan 150 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 309114, name = cephalexin 500 MG Oral Capsule, tty = SCD). Drug1 is resolved to hydrochlorothiazide, Drug2 is resolved to cephalexin anhydrous and interaction asserted in DrugBank between Hydrochlorothiazide and Cephalexin. Drug1 is resolved to irbesartan, Drug2 is resolved to cephalexin anhydrous and interaction asserted in DrugBank between Irbesartan and Cephalexin.

Drug1 (rxcui = 310431, name = gabapentin 300 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 854878, name = zolpidem tartrate 5 MG Oral Tablet [Ambien], tty = SBD). Drug1 is resolved to gabapentin, Drug2 is resolved to zolpidem and interaction asserted in DrugBank between Gabapentin and Zolpidem.

Drug1 (rxcui = 860512, name = 24 HR carvedilol phosphate 10 MG Extended Release Oral Capsule [Coreg], tty = SBD). Drug2 (rxcui = 310792, name = hydrochlorothiazide 12.5 MG / irbesartan 150 MG Oral Tablet, tty = SCD). Drug1 is resolved to carvedilol, Drug2 is resolved to irbesartan and interaction asserted in DrugBank between Carvedilol and Irbesartan.

zolpidem<>gabapentin enacarbil

Applies to: AMBIEN 5 MG Oral Tablet <> gabapentin 300 MG Oral Capsule

Drug1 (rxcui = 854878, name = zolpidem tartrate 5 MG Oral Tablet [Ambien], tty = SBD). Drug2 (rxcui = 310431, name = gabapentin 300 MG Oral Capsule, tty = SCD). Drug1 is resolved to zolpidem, Drug2 is resolved to gabapentin enacarbil and interaction asserted in DrugBank between Zolpidem and Gabapentin enacarbil.

Drug1 (rxcui = 197604, name = digoxin 0.125 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 310792, name = hydrochlorothiazide 12.5 MG / irbesartan 150 MG Oral Tablet, tty = SCD). Drug1 is resolved to digoxin, Drug2 is resolved to hydrochlorothiazide and interaction asserted in DrugBank between Digoxin and Hydrochlorothiazide. Drug1 is resolved to digoxin, Drug2 is resolved to irbesartan and interaction asserted in DrugBank between Digoxin and Irbesartan.

digoxin<>gabapentin enacarbil

Applies to: Digoxin 0.125 MG Oral Tablet <> gabapentin 300 MG Oral Capsule

Drug1 (rxcui = 197604, name = digoxin 0.125 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 310431, name = gabapentin 300 MG Oral Capsule, tty = SCD). Drug1 is resolved to digoxin, Drug2 is resolved to gabapentin enacarbil and interaction asserted in DrugBank between Digoxin and Gabapentin enacarbil.

gabapentin<>gabapentin enacarbil

Applies to: gabapentin 300 MG Oral Capsule <> gabapentin 300 MG Oral Capsule

Drug1 (rxcui = 310431, name = gabapentin 300 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 310431, name = gabapentin 300 MG Oral Capsule, tty = SCD). Drug1 is resolved to gabapentin, Drug2 is resolved to gabapentin enacarbil and interaction asserted in DrugBank between Gabapentin and Gabapentin enacarbil. Drug1 is resolved to gabapentin enacarbil, Drug2 is resolved to gabapentin and interaction asserted in DrugBank between Gabapentin enacarbil and Gabapentin.

gabapentin enacarbil<>cephalexin anhydrous

Applies to: gabapentin 300 MG Oral Capsule <> Cephalexin 500 MG Oral Capsule

Drug1 (rxcui = 310431, name = gabapentin 300 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 309114, name = cephalexin 500 MG Oral Capsule, tty = SCD). Drug1 is resolved to gabapentin enacarbil, Drug2 is resolved to cephalexin anhydrous and interaction asserted in DrugBank between Gabapentin enacarbil and Cephalexin.

Drug1 (rxcui = 310792, name = hydrochlorothiazide 12.5 MG / irbesartan 150 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 860512, name = 24 HR carvedilol phosphate 10 MG Extended Release Oral Capsule [Coreg], tty = SBD). Drug1 is resolved to hydrochlorothiazide, Drug2 is resolved to carvedilol and interaction asserted in DrugBank between Hydrochlorothiazide and Carvedilol.

Drug1 (rxcui = 310792, name = hydrochlorothiazide 12.5 MG / irbesartan 150 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 310431, name = gabapentin 300 MG Oral Capsule, tty = SCD). Drug1 is resolved to hydrochlorothiazide, Drug2 is resolved to gabapentin enacarbil and interaction asserted in DrugBank between Hydrochlorothiazide and Gabapentin enacarbil.

Drug1 (rxcui = 197604, name = digoxin 0.125 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 860512, name = 24 HR carvedilol phosphate 10 MG Extended Release Oral Capsule [Coreg], tty = SBD). Drug1 is resolved to digoxin, Drug2 is resolved to carvedilol and interaction asserted in DrugBank between Digoxin and Carvedilol.

digoxin<>cephalexin anhydrous

Applies to: Digoxin 0.125 MG Oral Tablet <> Cephalexin 500 MG Oral Capsule

Drug1 (rxcui = 197604, name = digoxin 0.125 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 309114, name = cephalexin 500 MG Oral Capsule, tty = SCD). Drug1 is resolved to digoxin, Drug2 is resolved to cephalexin anhydrous and interaction asserted in DrugBank between Digoxin and Cephalexin.

Drug1 (rxcui = 309114, name = cephalexin 500 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 197604, name = digoxin 0.125 MG Oral Tablet, tty = SCD). Drug1 is resolved to cephalexin, Drug2 is resolved to digoxin and interaction asserted in DrugBank between Cephalexin and Digoxin.

No other interactions were found between your selected drugs.

Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.